Dr. Lesh is currently the CEO and founder of the data science and data privacy company Syntegra. Additionally, he serves as the executive chair of Cordance Medical, a company that uses transcranial-focused ultrasounds to treat cancer, Alzheimer’s and other brain diseases, according to a Nov. 3 Elucid news release.
“The Elucid technology is poised to become the standard of care for non-invasive diagnosis of cardiovascular disease, and I look forward to working with the company to make this a reality,” Dr. Lesh said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.